Kidney Diseases

• 

  Subject Areas on Research

  • 10-year survey of referrals to a pediatric nephrology program. 
  • A blueprint for randomized trials targeting phosphorus metabolism in chronic kidney disease. 
  • A combined clinical and biomarker approach to predict diuretic response in acute heart failure. 
  • A comparison of the efficacy and safety of iopamidol-370 and iodixanol-320 in patients undergoing multidetector-row computed tomography. 
  • A decade after the KDOQI CKD guidelines: a perspective from South Asia. 
  • A genetic approach for studying the role of thromboxane A2 in the kidney. 
  • A novel approach to the treatment of chronic allograft nephropathy. 
  • A proposed taxonomy for the podocytopathies: a reassessment of the primary nephrotic diseases. 
  • A prospective study of outcomes of nursing home residents with chronic kidney disease with and without anemia. 
  • A protocol of early spiral computed tomography for the detection of stones in patients with renal colic has reduced the time to diagnosis and overall management costs. 
  • A radiologic syndrome after high dose chemotherapy and autologous bone marrow transplantation, with clinical and pathologic features of systemic candidiasis. 
  • A reference tissue atlas for the human kidney. 
  • A role for leukotrienes in cyclosporine nephrotoxicity. 
  • A secondary analysis of the CHOIR trial shows that comorbid conditions differentially affect outcomes during anemia treatment. 
  • ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension. 
  • APOL1 Kidney Risk Variants and Cardiovascular Disease: An Individual Participant Data Meta-Analysis. 
  • APOL1 Nephrotoxicity: What Does Ion Transport Have to Do With It? 
  • APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinases. 
  • APOL1-G0 or APOL1-G2 Transgenic Models Develop Preeclampsia but Not Kidney Disease. 
  • Absence of biochemical evidence for renal and hepatic dysfunction after 8 hours of 1.25 minimum alveolar concentration sevoflurane anesthesia in volunteers. 
  • Accuracy of radionuclide imaging in distinguishing renal masses from normal variants. 
  • Activation of Galpha q-coupled signaling pathways in glomerular podocytes promotes renal injury. 
  • Acute kidney injury and cardiovascular outcomes in acute severe hypertension. 
  • Acute renal failure and pigmentation due to phenazopyridine (Pyridium). 
  • Acute renal failure due to perirenal hematoma complicating open renal biopsy. 
  • Acute tubular necrosis; analysis of one hundred cases with respect to mortality, complications, and treatment with and without dialysis. 
  • Adeno-associated virus gene transfer into renal cells: potential for in vivo gene delivery. 
  • Advanced chronic kidney disease practice patterns among nephrologists and non-nephrologists: a database analysis. 
  • Advances in digital imaging during endoscopic surgery. 
  • Advances in the biology and genetics of the podocytopathies: implications for diagnosis and therapy. 
  • Agalsidase-beta therapy for advanced Fabry disease: a randomized trial. 
  • Age-related decline in urine concentration may not be universal: Comparative study from the U.S. and two small-scale societies. 
  • Age-specific associations of reduced estimated glomerular filtration rate with concurrent chronic kidney disease complications. 
  • Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions. 
  • Albuminuria: is it time to screen the general population? 
  • Alemtuzumab induction and recurrence of glomerular disease after kidney transplantation. 
  • Alterations in renal function in psoriasis patients treated with cyclosporine, 5 mg/kg/day. 
  • Amelioration of proximal renal tubular dysfunction in type I glycogen storage disease with dietary therapy. 
  • Analysis of renal cell transformation following exposure to trichloroethene in vivo and its metabolite S-(dichlorovinyl)-L-cysteine in vitro. 
  • Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology. 
  • Angiotensin converting enzyme 2 and the kidney. 
  • Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. 
  • Antecedent renal disease and the outcome of pregnancy. 
  • Antenatal Bartter's syndrome: why is this not a lethal condition? 
  • Antioxidant nutrients protect against cyclosporine A nephrotoxicity. 
  • Antiretroviral therapy and the kidney. 
  • Antiretroviral therapy and the kidney: balancing benefit and risk in patients with HIV infection. 
  • Antithrombotic Treatment of Embolic Stroke of Undetermined Source: RE-SPECT ESUS Elderly and Renally Impaired Subgroups. 
  • Apolipoprotein E polymorphism and the risk of acute nephropathy after cardiac surgery. 
  • Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure. 
  • Aspirin use and outcomes in a community-based cohort of 7352 patients discharged after first hospitalization for heart failure. 
  • Assessment of a computerized quantitative quality control tool for whole slide images of kidney biopsies. 
  • Association Between Change in Central Nocturnal Blood Pressure and Urine Albumin-Creatinine Ratio by a Valsartan/Amlodipine Combination: A CPET Study. 
  • Association between estimated glomerular filtration rate and clinical outcomes in patients with acute ischaemic stroke: results from China National Stroke Registry. 
  • Association between goal-striving stress and rapid kidney function decline among African Americans: the Jackson Heart Study. 
  • Association between major depressive episodes in patients with chronic kidney disease and initiation of dialysis, hospitalization, or death. 
  • Association of Kidney Disease Quality of Life (KDQOL-36) with mortality and hospitalization in older adults receiving hemodialysis. 
  • Association of a reduction in central obesity and phosphorus intake with changes in urinary albumin excretion: the PREMIER study. 
  • Association of antihypertensive therapy and diastolic hypotension in chronic kidney disease. 
  • Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. 
  • Atrial fibrillation and kidney disease: stuck outside the CABANA. 
  • Attitudes of patients with renal disease on xenotransplantation: A systematic review. 
  • Azotemic renal osteodystrophy. 
  • BK virus and SV40 co-infection in polyomavirus nephropathy. 
  • Balanced Crystalloids versus Saline in Noncritically Ill Adults. 
  • Banff Digital Pathology Working Group: Going digital in transplant pathology. 
  • Benefits, risk, and uncertainty: preferences of antiretroviral-naïve African Americans for HIV treatments. 
  • Bioavailability of phosphorus and kidney function in the Jackson Heart Study. 
  • Biological monitoring for occupational cadmium exposure: the urinary metallothionein. 
  • Biomarkers of impaired renal function. 
  • Brief Report: Kidney Dysfunction Does Not Contribute Significantly to Antiretroviral Therapy Modification in Treatment-Naive PLWH Receiving Initial ART. 
  • C-C Motif Chemokine 5 Attenuates Angiotensin II-Dependent Kidney Injury by Limiting Renal Macrophage Infiltration. 
  • CKD increases the risk of age-related macular degeneration. 
  • CKD progression and mortality among older patients with diabetes. 
  • CYP3A4 and CYP3A5 polymorphisms and blood pressure response to amlodipine among African-American men and women with early hypertensive renal disease. 
  • Can We Cure Light Chain Deposition Disease of the Kidneys?-A Review and Case Report of a Patient Treated With a Triple Transplant Approach. 
  • Candidal mycetoma in the neonatal kidney. 
  • Cardiac resynchronization therapy in patients with renal dysfunction: keep calm and carry on. 
  • Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes. 
  • Cardiovascular and renal toxicity of a nonionic radiographic contrast agent after cardiac catheterization. A prospective trial. 
  • Case 6-2011: Aortic valve replacement in a patient with aortic stenosis, dilated cardiomyopathy, and renal dysfunction. 
  • Case of the month misdiagnosis. 
  • Central corneal thickness and its associations with ocular and systemic factors: the Singapore Malay Eye Study. 
  • Challenges for public campaigns to improve the health of persons at high risk of developing CKD. 
  • Changes in cardiac troponin T measurements are associated with adverse cardiac events in patients with chronic kidney disease. 
  • Characteristics and in-hospital outcomes of patients with non-ST-segment elevation myocardial infarction and chronic kidney disease undergoing percutaneous coronary intervention. 
  • Chemical evidence for early but unsustained growth in the obstructed mouse kidney. 
  • Chronic allograft nephropathy uniformly affects recipients of cadaveric, nonidentical living-related, and living-unrelated grafts. 
  • Chronic kidney disease is associated with increased risk of sudden cardiac death among patients with coronary artery disease. 
  • Chronic kidney disease, hypovitaminosis D, and mortality in the United States. 
  • Circulating cryoglobulins in nephropathic cystinosis. 
  • Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities. 
  • Clinical problem-solving. Needle in a haystack. 
  • Clinical study of the cardiac findings in patients on chronic maintenance hemodialysis: the relationship to coronary risk factors. 
  • Clinical testing patterns and cost implications of variation in the evaluation of CKD among US physicians. 
  • Clostridium difficile infection among kidney transplant recipients: frequency, clinical presentation, and outcome. 
  • Cogan's syndrome and development of ANCA-associated renal vasculitis after lengthy disease remission. 
  • Comparative Effect of Contrast Media Type on the Incidence of Contrast-Induced Nephropathy: A Systematic Review and Meta-analysis. 
  • Comparative effectiveness research in kidney disease: a national priority. 
  • Comparison of Gene Delivery to the Kidney by Adenovirus, Adeno-Associated Virus, and Lentiviral Vectors After Intravenous and Direct Kidney Injections. 
  • Compensatory renal growth after unilateral ureteral obstruction. 
  • Competing Mortality in Patients With Neuroendocrine Tumors. 
  • Compression CT urography: a comparison with IVU in the opacification of the collecting system and ureters. 
  • Computerized medical records. A new resource for clinical decision making. 
  • Consensus Report by the Pediatric Acute Lung Injury and Sepsis Investigators and Pediatric Blood and Marrow Transplant Consortium Joint Working Committees on Supportive Care Guidelines for Management of Veno-Occlusive Disease in Children and Adolescents: Part 2-Focus on Ascites, Fluid and Electrolytes, Renal, and Transfusion Issues. 
  • Consensus definitions for glomerular lesions by light and electron microscopy: recommendations from a working group of the Renal Pathology Society. 
  • Constructing a database of individual clinical trials for longitudinal analysis. 
  • Continuous renal replacement therapy for children ≤10 kg: a report from the prospective pediatric continuous renal replacement therapy registry. 
  • Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography: a double-blind comparison of iodixanol and iopamidol. 
  • Control of blood pressure in chronic kidney disease: how low to go? 
  • Controlled trial comparing co-trimoxazole and methenamine hippurate in the prevention of recurrent urinary tract infections. 
  • Correlates of osteoprotegerin and association with aortic pulse wave velocity in patients with chronic kidney disease. 
  • Correlation of total and interstrand DNA adducts in tumor and kidney with antitumor efficacies and differential nephrotoxicities of cis-ammine/cyclohexylamine-dichloroplatinum(II) and cisplatin. 
  • Cost-effectiveness of screening for proteinuria. 
  • Cumulative CT exposures in emergency department patients evaluated for suspected renal colic. 
  • Current best practices and guidelines. Assessment and management of complications in infective endocarditis. 
  • Current best practices and guidelines. Assessment and management of complications in infective endocarditis. 
  • Cyclosporine increases local glomerular synthesis of reactive oxygen species in rats: effect of vitamin E on cyclosporine nephrotoxicity. 
  • Cyclosporine nephrotoxicity: a workshop to discuss mechanisms, diagnosis, and treatment. 
  • Cyclosporine therapy and the development of interstitial fibrosis in renal allografts. 
  • Cytomegalovirus infection and chronic hemodialysis. 
  • Cytotoxicity of S-conjugates of the sevoflurane degradation product fluoromethyl-2,2-difluoro-1-(trifluoromethyl) vinyl ether (Compound A) in a human proximal tubular cell line. 
  • DRIVE it home: making the case for prospective economic data collection in randomized clinical trials. 
  • Deep-Learning-Driven Quantification of Interstitial Fibrosis in Digitized Kidney Biopsies. 
  • Deficiency of Adenosine Deaminase 2 in Adults and Children: Experience From India. 
  • Defining measures of kidney function in observational studies using routine health care data: methodological and reporting considerations. 
  • Depression in elderly hospitalized patients with medical illness. 
  • Detection in human serum by radioimmunoassay of histidyl-proline diketopiperazine, a metabolite of thyrotropin-releasing hormone. 
  • Detection of ureteral calculi in patients with suspected renal colic: value of reformatted noncontrast helical CT. 
  • Determinants of 15-year outcome with 1,119 standard Carpentier-Edwards porcine valves. 
  • Determinants of retinal venular diameter: the Beaver Dam Eye Study. 
  • Diagnostic workup of renal disorders. 
  • Dietary fumonisin B1 induces disruption of sphingolipid metabolism in Sprague-Dawley rats: a new mechanism of nephrotoxicity. 
  • Differential Response to Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure With Reduced or Preserved Ejection Fraction: Results From the ROSE AHF Trial (Renal Optimization Strategies Evaluation in Acute Heart Failure). 
  • Digital pathology and computational image analysis in nephropathology. 
  • Digital pathology in nephrology clinical trials, research, and pathology practice. 
  • Discussions of the kidney disease trajectory by elderly patients and nephrologists: a qualitative study. 
  • Disseminated zygomycosis: report of four cases and review. 
  • Dissemination of Evidence-based Practice Center reports. 
  • Donor genomics influence graft events: the effect of donor polymorphisms on acute rejection and chronic allograft nephropathy. 
  • Drug Development in Kidney Disease: Proceedings From a Multistakeholder Conference. 
  • Dual-Energy MDCT for Imaging the Renal Mass. 
  • Earlier onset and greater severity of disordered mineral metabolism in diabetic patients with chronic kidney disease. 
  • Early and limited use of tacrolimus to avoid rejection in an alemtuzumab and sirolimus regimen for kidney transplantation: clinical results and immune monitoring. 
  • Editorial comment. 
  • Editorial comment. 
  • Efavirenz: innocent bystander or direct nephrotoxin? 
  • Effect of angiotensin-converting enzyme inhibitors on progression of nondiabetic renal disease. 
  • Effect of anti-CD4 antibody treatment on inflammatory arthritis in MRL-lpr/lpr mice. 
  • Effect of gadolinium chelate contrast agents on diffusion weighted MR imaging of the liver, spleen, pancreas and kidney at 3 T. 
  • Effect of low-dose prophylactic dopamine on high-dose cisplatin-induced electrolyte wasting, ototoxicity, and epidermal growth factor excretion: a randomized, placebo-controlled, double-blind trial. 
  • Effect of nesiritide in patients with acute decompensated heart failure. 
  • Effectiveness of Prevention Strategies for Contrast-Induced Nephropathy: A Systematic Review and Meta-analysis. 
  • Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial. 
  • Effects of serelaxin in acute heart failure patients with renal impairment: results from RELAX-AHF. 
  • Effects of sodium-glucose cotransporter 1 and 2 inhibitors on cardiovascular and kidney outcomes in type 2 diabetes: A meta-analysis update. 
  • Effects of the adenosine A1 receptor antagonist rolofylline on renal function in patients with acute heart failure and renal dysfunction: results from PROTECT (Placebo-Controlled Randomized Study of the Selective Adenosine A1 Receptor Antagonist Rolofylline for Patients Hospitalized with Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function). 
  • Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation in Relation to Renal Function Over Time: Insights From the ARISTOTLE Randomized Clinical Trial. 
  • Efficacy and toxicity of cyclosporine in chronic progressive multiple sclerosis: a randomized, double-blinded, placebo-controlled clinical trial. The Multiple Sclerosis Study Group. 
  • Electron microscopy in renal pathology: overall applications and guidelines for tissue, collection, preparation, and stains. 
  • Elevated urinary neutrophil gelatinase-associated lipocalcin after acute heart failure treatment is associated with worsening renal function and adverse events. 
  • Embolic protection and platelet inhibition during renal artery stenting. 
  • Emerging Viral Infections and the Potential Impact on Hypertension, Cardiovascular Disease, and Kidney Disease. 
  • Emerging immunotherapies for autoimmune kidney disease. 
  • Employing Macrophage-Derived Microvesicle for Kidney-Targeted Delivery of Dexamethasone: An Efficient Therapeutic Strategy against Renal Inflammation and Fibrosis. 
  • Endoscopic management of symptomatic caliceal diverticula: a retrospective comparison of percutaneous nephrolithotripsy and ureteroscopy. 
  • Endothelin-receptor blockade mitigates the adverse effect of preretrieval warm ischemia on posttransplantation renal function in rats. 
  • Epidemiology, Comorbidities, and Outcomes of Posterior Reversible Encephalopathy Syndrome in Children in the United States. 
  • Erythropoiesis-stimulating agents increase the risk of acute stroke in patients with chronic kidney disease. 
  • Establishing a pragmatic framework to optimise health outcomes in heart failure and multimorbidity (ARISE-HF): A multidisciplinary position statement. 
  • Establishing patient-specific criteria for selecting the optimal upper extremity vascular access procedure. 
  • Estimated net endogenous acid production and serum bicarbonate in African Americans with chronic kidney disease. 
  • Ethnic disparities in prevalence and impact of risk factors of chronic kidney disease. 
  • Etiology of Persistent Microalbuminuria in Nigeria (P_MICRO study): protocol and study design. 
  • Evaluation of a CD5-specific immunotoxin for treatment of acute graft-versus-host disease after allogeneic marrow transplantation. 
  • Eventual attenuation of hypocalciuric response to hydrochlorothiazide in absorptive hypercalciuria. 
  • Evidence For and Against Direct Kidney Infection by SARS-CoV-2 in Patients with COVID-19. 
  • Evidence-based renal protection in cardiac surgery. 
  • Evolutionary genetics and acclimatization in nephrology. 
  • Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism. 
  • Experimental inhibition of porcupine-mediated Wnt O-acylation attenuates kidney fibrosis. 
  • Exploring the generalist-subspecialist interface in internal medicine. 
  • Expression of clusterin in human renal diseases. 
  • Expression of human complement factor H prevents age-related macular degeneration-like retina damage and kidney abnormalities in aged Cfh knockout mice. 
  • FGF23 and Nutritional Metabolism. 
  • FGF23 in chronic kidney disease. 
  • FGF23 or PTH: which comes first in CKD ? 
  • FGF23: fashion or physiology? 
  • Facilitated process improvement: an approach to the seamless linkage between evidence and practice in CKD. 
  • Factors associated with decreased kidney function in HIV-infected adults enrolled in the MTCT-Plus Initiative in sub-Saharan Africa. 
  • Familial hyperuricemia and renal insufficiency. 
  • Fanconi syndrome accompanied by renal function decline with tenofovir disoproxil fumarate: a prospective, case-control study of predictors and resolution in HIV-infected patients. 
  • Fatal SV40-associated pneumonia and nephropathy following renal allotransplantation in rhesus macaque. 
  • Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. 
  • Fetal origins of renal disparities. 
  • Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. 
  • Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. 
  • Fibroblast growth factor 23 and the future of phosphorus management. 
  • Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. 
  • Fine-needle aspiration findings in idiopathic retroperitoneal fibrosis. 
  • First-in-human experience with Aortix intraaortic pump. 
  • Forging forward with 10 burning questions on FGF23 in kidney disease. 
  • Fractal analysis of the retinal vasculature and chronic kidney disease. 
  • From man to fish: What can Zebrafish tell us about ApoL1 nephropathy? 
  • Gene expression profiling of nephrotoxicity from the sevoflurane degradation product fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether ("compound A") in rats. 
  • Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci. 
  • Genetic control of inflammatory arthritis in congenic lpr mice. 
  • Genetic determinants of renal transplant outcome: where do we stand? 
  • Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. 
  • Genitourinary complications of sickle cell disease. 
  • Genome-wide mutational signatures of aristolochic acid and its application as a screening tool. 
  • Genotype-phenotype correlation in MYH9-related thrombocytopenia. 
  • Getting (Left Atrial Appendage) Closure With Kidney Disease. 
  • Global Cardiovascular and Renal Outcomes of Reduced GFR. 
  • Glomerular atrial natriuretic factor receptors in primary glomerulopathies: studies on human renal biopsies. 
  • Glomerular filtration rate estimated using creatinine, cystatin C or both markers and the risk of clinical events in HIV-infected individuals. 
  • Glomerular grievances and CKD. 
  • Glycated hemoglobin and the risk of kidney disease and retinopathy in adults with and without diabetes. 
  • Glycogen storage disease types I and II: treatment updates. 
  • Gone but not forgotten: resolution of childhood kidney disease and the risk of end-stage kidney disease in adults. 
  • Graft Kidney Torsion After Simultaneous Kidney-Pancreas Transplant: Report of 2 Cases and Literature Review. 
  • HIV-1 infection of the kidney: mechanisms and implications. 
  • Half-life analysis of pancreas and kidney transplants. 
  • Helical (spiral) CT of the retroperitoneum. 
  • Helical CT of the urinary tract. 
  • Hematopoietic stem-cell transplantation. 
  • Hepatitis C and the risk of kidney disease and mortality in veterans with HIV. 
  • Hepatorenal dysfunction identifies high-risk patients with acute heart failure: insights from the RELAX-AHF trial. 
  • Hereditary renal disease and preauricular pits: report of a kindred. 
  • High CTLA-4 expression on Th17 cells results in increased sensitivity to CTLA-4 coinhibition and resistance to belatacept. 
  • Horseshoe kidney transplantation. 
  • Hospital performance and differences by kidney function in the use of recommended therapies after non-ST-elevation acute coronary syndromes. 
  • Hospital-associated venous thromboembolism in children: incidence and clinical characteristics. 
  • Human kidney methoxyflurane and sevoflurane metabolism. Intrarenal fluoride production as a possible mechanism of methoxyflurane nephrotoxicity. 
  • Hyperkalemia: a review. 
  • Hypertension and kidney disease in Asia. 
  • Hypertension, chronic kidney disease, and the development of cardiovascular risk: a joint primacy. 
  • Hypertension: a new look at an old problem. 
  • Hypertensive Disorders of Pregnancy With and Without Prepregnancy Hypertension Are Associated With Incident Maternal Kidney Disease Subsequent to Delivery. 
  • Ideal high sensitivity troponin baseline cutoff for patients with renal dysfunction. 
  • Identification and referral of patients with progressive CKD: a national study. 
  • IgA and IgG antineutrophil cytoplasmic antibody engagement of Fc receptor genetic variants influences granulomatosis with polyangiitis. 
  • IgA-containing circulating immune complexes in patients with igA nephropathy. 
  • Ignoring the obvious missing piece of chronic kidney disease in HIV: cigarette smoking. 
  • Images in clinical medicine. Pseudoclubbing. 
  • Imaging findings of hemorrhagic cystitis in pediatric oncology patients. 
  • Immunologic risks of combined kidney-pancreas transplantation. 
  • Impact of acute kidney injury on chronic kidney disease and its progression. 
  • Impact of anemia on physical function and survival among patients with coronary artery disease. 
  • Impact of chronic kidney disease on activities of daily living in community-dwelling older adults. 
  • Impact of chronic kidney disease on early (30-day) and late (1-year) outcomes of patients with acute coronary syndromes treated with alternative antithrombotic treatment strategies: an ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) substudy. 
  • Impact of estimated GFR reporting on patients, clinicians, and health-care systems: a systematic review. 
  • Impact of renal dysfunction on outcomes of coronary artery bypass surgery: results from the Society of Thoracic Surgeons National Adult Cardiac Database. 
  • Implanted coil MR microscopy of renal pathology. 
  • Implications of Cross-System Use Among US Veterans With Advanced Kidney Disease in the Era of the MISSION Act: A Qualitative Study of Health Care Records. 
  • Improving Clinical Trials for Anticomplement Therapies in Complement-Mediated Glomerulopathies: Report of a Scientific Workshop Sponsored by the National Kidney Foundation. 
  • Improving the clinical value of estimating glomerular filtration rate by reporting all values: a contrarian viewpoint. 
  • Incidence and Diagnostic Challenges of Bowel Ischemia after Continuous-flow Left Ventricular Assist Device Therapy. 
  • Incorporating SGLT2i and GLP-1RA for Cardiovascular and Kidney Disease Risk Reduction: Call for Action to the Cardiology Community. 
  • Increased serum levels of macrophage colony-stimulating factor in ovarian cancer. 
  • Induction of ERK1/2 and histone H3 phosphorylation within the outer stripe of the outer medulla of the Eker rat by 2,3,5-tris-(glutathion-S-yl)hydroquinone. 
  • Induction of clusterin in acute and chronic oxidative renal disease in the rat and its dissociation from cell injury. 
  • Inflammation and Immunity Pathways Regulate Genetic Susceptibility to Diabetic Nephropathy. 
  • Influence of comorbidity on racial differences in receipt of surgery among US veterans with early-stage non-small-cell lung cancer. 
  • Innovating and invigorating the clinical trial infrastructure for glomerular diseases. 
  • Intensity and focus of heart failure disease management after hospital discharge. 
  • Intermittent ureteropelvic junction obstruction in the adult. 
  • Interplay between vesicoureteric reflux and kidney infection in the development of reflux nephropathy in mice. 
  • Is the height/plasma creatinine formula of Schwartz useful as a screening test in detecting Nigeria children with low GFR? 
  • Is there a multiplicative adverse effect of cardiovascular and kidney disease on neuropsychological measures? 
  • Is there transfusion-related acute renal injury? 
  • Ischemic injury to kidney induces glomerular podocyte effacement and dissociation of slit diaphragm proteins Neph1 and ZO-1. 
  • JAK inhibitor blocks COVID-19 cytokine-induced JAK/STAT/APOL1 signaling in glomerular cells and podocytopathy in human kidney organoids. 
  • KLF4 in Macrophages Attenuates TNFα-Mediated Kidney Injury and Fibrosis. 
  • Kidney Biopsy Features Most Predictive of Clinical Outcomes in the Spectrum of Minimal Change Disease and Focal Segmental Glomerulosclerosis. 
  • Kidney Disease and HIV Infection. 
  • Kidney and eye diseases: common risk factors, etiological mechanisms, and pathways. 
  • Kidney changes after extracorporeal shock wave lithotripsy: appearance on MR imaging. 
  • Kidney disease in HIV infection: introduction. 
  • Kidney disease in antiretroviral-naïve HIV-positive adults with high CD4 counts: prevalence and predictors of kidney disease at enrolment in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. 
  • Kidney disease in patients with HIV infection and AIDS. 
  • Kidney disease other than renal crisis in patients with diffuse scleroderma. 
  • Kidney injury biomarkers and urinary creatinine variability in nominally healthy adults. 
  • Lack of Duffy antigen expression is associated with organ damage in patients with sickle cell disease. 
  • Leflunomide for polyomavirus type BK nephropathy. 
  • Leontiasis ossea in secondary hyperparathyroidism. 
  • Less is More: Deprescribing Medications in Older Adults with Kidney Disease: A Review. 
  • Leucine-rich repeat kinase 2 deficiency is protective in rhabdomyolysis-induced kidney injury. 
  • Level and Change in N-Terminal Pro-B-Type Natriuretic Peptide and Kidney Function and Survival to Age 90. 
  • Life Course Socioeconomic Status, Allostatic Load, and Kidney Health in Black Americans. 
  • Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINA. 
  • Lipid formulations of amphotericin B preserve and stabilize renal function in HSCT recipients. 
  • Long-term management of the liver transplant patient: recommendations for the primary care doctor. 
  • Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial. 
  • Luminal alkalinization attenuates proteinuria-induced oxidative damage in proximal tubular cells. 
  • MRI tools for assessment of microstructure and nephron function of the kidney. 
  • MYH9 and APOL1 are both associated with sickle cell disease nephropathy. 
  • Magnetic resonance histology of age-related nephropathy in the Sprague Dawley rat. 
  • Magnetic resonance microscopy of toxic renal injury induced by bromoethylamine in rats. 
  • Management of calyceal calculi. 
  • Management of postoperative atrial fibrillation and subsequent outcomes in contemporary patients undergoing cardiac surgery: insights from the Society of Thoracic Surgeons CAPS-Care Atrial Fibrillation Registry. 
  • Managing older adults with CKD: individualized versus disease-based approaches. 
  • Marrow transplantation for leukemia following fractionated total body irradiation. A comparative trial of methotrexate and cyclosporine. 
  • Mechanisms of ischemic injury are different in the steatotic and normal rat liver. 
  • Medical qualification of a commercial spaceflight participant: not your average astronaut. 
  • Megalin/Cubulin-Lysosome-mediated Albumin Reabsorption Is Involved in the Tubular Cell Activation of NLRP3 Inflammasome and Tubulointerstitial Inflammation. 
  • Methyldopa therapy and outcome in cadaveric renal transplantation. 
  • Microalbuminuria predicts overt proteinuria among patients with HIV infection. 
  • Microdialysis assessment of shock wave lithotripsy-induced renal injury. 
  • Mineral metabolism: confusion to clarity. 
  • Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction: integrating evidence into clinical practice. 
  • Minimal mortality of renal surgery. 
  • Minimal risk of chronic renal dysfunction in marrow transplant recipients treated with cyclosporine for 6 months. 
  • Modelling kidney disease using ontology: insights from the Kidney Precision Medicine Project. 
  • Modifier locus on mouse chromosome 3 for renal vascular pathology in AT1A receptor-deficiency. 
  • Molecular biology of renal injury: emphasis on the role of the renin-angiotensin system. 
  • Molecular mechanisms of immunosuppression by cyclosporine, FK506, and rapamycin. 
  • Molecular therapy for renal diseases. 
  • Morphology in the Digital Age: Integrating High-Resolution Description of Structural Alterations With Phenotypes and Genotypes. 
  • Morphometry Predicts Early GFR Change in Primary Proteinuric Glomerulopathies: A Longitudinal Cohort Study Using Generalized Estimating Equations. 
  • Mortality, kidney disease and cardiac procedures following acute coronary syndrome. 
  • Mouse models of MYH9-related disease: mutations in nonmuscle myosin II-A. 
  • Multi-institutional assessment of ureteroscopic laser papillotomy for chronic flank pain associated with papillary calcifications. 
  • Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive and ANCA-Negative Patients With Granulomatosis With Polyangiitis (Wegener's): Distinct Patient Subsets. 
  • N-acetylcysteine for the prevention of radiocontrast induced nephropathy: a meta-analysis of prospective controlled trials. 
  • Near-term prediction of sudden cardiac death in older hemodialysis patients using electronic health records. 
  • Negative trials in nephrology: what can we learn? 
  • Neonatal methylmercury poisoning in the rat: effects on development of peripheral sympathetic nervous system. Neuronal participation in methylmercury-induced cardiac and renal overgrowth. 
  • Nephrogenic systemic fibrosis risk after liver magnetic resonance imaging with gadoxetate disodium in patients with moderate to severe renal impairment: results of a prospective, open-label, multicenter study. 
  • Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection. 
  • Nephrotoxicity and hepatotoxicity induced by inhaled bromodichloromethane in wild-type and p53-heterozygous mice. 
  • Nephrotoxicity from contrast material in renal insufficiency: ionic versus nonionic agents. 
  • New insights into the mechanism of methoxyflurane nephrotoxicity and implications for anesthetic development (part 1): Identification of the nephrotoxic metabolic pathway. 
  • New insights into the mechanism of methoxyflurane nephrotoxicity and implications for anesthetic development (part 2): Identification of nephrotoxic metabolites. 
  • Newer knowledge of vitamin D and its metabolites in health and disease. 
  • Noncardiac comorbidities and acute heart failure patients. 
  • Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction. 
  • Nonenhanced helical CT and US in the emergency evaluation of patients with renal colic: prospective comparison. 
  • Notch signaling: a common pathway of injury in podocytopathies? 
  • Observational Research Using Propensity Scores. 
  • Obstructive nephropathy in the rat: possible roles for the renin-angiotensin system, prostaglandins, and thromboxanes in postobstructive renal function. 
  • Optimal timing of hydration to erase contrast-associated nephropathy: the OTHER CAN study. 
  • Organ cross talk in the critically ill: the heart and kidney. 
  • Organoid single cell profiling identifies a transcriptional signature of glomerular disease. 
  • Osteoporosis piece of multi-morbidity puzzle in geriatric care. 
  • Outcomes After Transcatheter Mitral Valve Repair in Patients With Renal Disease. 
  • Overview of first-line amikacin therapy for urologic infections. 
  • Pathogenesis and treatment of HIV-associated renal diseases: lessons from clinical and animal studies, molecular pathologic correlations, and genetic investigations. 
  • Pathophysiology and clinical evaluation of acute heart failure. 
  • Patients as stakeholders in setting kidney disease research priorities. 
  • Perfluorinated Chemicals as Emerging Environmental Threats to Kidney Health: A Scoping Review. 
  • Perioperative nesiritide and possible renal protection in patients with moderate to severe kidney dysfunction. 
  • Perioperative renal dysfunction and cardiovascular anesthesia: concerns and controversies. 
  • Pharmacokinetics of lamivudine in human immunodeficiency virus-infected patients with renal dysfunction. 
  • Phase I and pharmacokinetic study of erlotinib for solid tumors in patients with hepatic or renal dysfunction: CALGB 60101. 
  • Phase I trial of carboplatin and infusional cyclosporin in advanced malignancy. 
  • Phenotype and function of T cells propagated from donor-specific blood transfusion enhanced and autologous blood transfused rejecting rat renal allografts. 
  • Physicochemical characteristics and biological effects of nickel oxides. 
  • Population-based screening for CKD. 
  • Potential kidney toxicity from the antiviral drug tenofovir: new indications, new formulations, and a new prodrug. 
  • Precipitating Clinical Factors, Heart Failure Characterization, and Outcomes in Patients Hospitalized With Heart Failure With Reduced, Borderline, and Preserved Ejection Fraction. 
  • Predicting renal outcomes in children with anterior urethral valves: a systematic review. 
  • Prediction and validation of exenatide risk marker effects on progression of renal disease: Insights from EXSCEL. 
  • Predictive value of myocardial perfusion single-photon emission computed tomography and the impact of renal function on cardiac death. 
  • Predictors of childhood obesity and pathogenesis of comorbidities. 
  • Predictors of mortality in patients with chronic kidney disease and an implantable defibrillator: an EPGEN substudy. 
  • Predictors of reduced dose intensity in patients with early-stage breast cancer receiving adjuvant chemotherapy. 
  • Pregnancy outcomes in a prospective matched control study of pregnancy and renal disease. 
  • Prehypertension and chronic kidney disease: the ox or the plow? 
  • Pretransplant predictors of recovery of renal function after liver transplantation. 
  • Prevalence and Associations of Retinal Emboli With Ethnicity, Stroke, and Renal Disease in a Multiethnic Asian Population: The Singapore Epidemiology of Eye Disease Study. 
  • Prevalence and clinical correlates of glomerulopathy in children with sickle cell disease. 
  • Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the evaluation of drug eluting stents and ischemic events registry. 
  • Prevalence of kidney disease in HIV-infected and uninfected Rwandan women. 
  • Preventing renal dysfunction in patients with hypertension: clinical implications from the early AASK Trial results. 
  • Prevention Strategies for Contrast-Induced Nephropathy. 
  • Prevention of experimental cyclosporin-induced interstitial fibrosis by losartan and enalapril. 
  • Primary Plasma Cell Neoplasm of the Kidney Without Formation of a Mass and Its Renal Manifestations: An Interstitial Variant of Renal Plasmacytoma? 
  • Primary care-specialist collaboration in the care of patients with chronic kidney disease. 
  • Principles of screening for chronic kidney disease. 
  • Prioritizing the quality of life of older adults with kidney disease. 
  • Proceedings of the Guideline Workshop 2019 - Strategies for the optimization of guideline processes in diabetes, cardiovascular diseases and kidney diseases. 
  • Proceedings of the Guideline Workshop 2019: Strategies for the Optimization of Guideline Processes in Diabetes, Cardiovascular Diseases, and Kidney Diseases. 
  • Prognostic value of bone- and vascular-derived molecular biomarkers in hemodialysis and renal transplant patients: a systematic review and meta-analysis. 
  • Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. 
  • Prolonged survival with a remnant kidney. 
  • Propagation of shock waves in elastic solids caused by cavitation microjet impact. II: Application in extracorporeal shock wave lithotripsy. 
  • Prophylactic hydration to prevent contrast-induced nephropathy: much ado about nothing? 
  • Propionibacterium shunt nephritis in two adolescents with medulloblastoma. 
  • Proposed high-risk screening protocol for Fabry disease in patients with renal and vascular disease. 
  • Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease. 
  • Pulse pressure and vascular risk in the elderly: associations and clinical implications. 
  • Quality of care and outcomes among patients with heart failure and chronic kidney disease: A Get With the Guidelines -- Heart Failure Program study. 
  • Quality of patient-physician discussions about CKD in primary care: a cross-sectional study. 
  • Quantification of Glomerular Structural Lesions: Associations With Clinical Outcomes and Transcriptomic Profiles in Nephrotic Syndrome. 
  • RNA sequencing of isolated cell populations expressing human APOL1 G2 risk variant reveals molecular correlates of sickle cell nephropathy in zebrafish podocytes. 
  • Race-Free Estimation of Kidney Function: Clearing the Path Toward Kidney Health Equity. 
  • Racial and Ethnic Disparities in Acute Care Utilization Among Patients With Glomerular Disease. 
  • Racial differences in long-term outcomes among black and white patients with drug-eluting stents. 
  • Racial differences in postprandial mineral ion handling in health and in chronic kidney disease. 
  • Racial differences in the incidence and progression of renal diseases. 
  • Racism and Kidney Health: Turning Equity Into a Reality. 
  • Radiation injury of the kidney. 
  • Radiocontrast nephropathy: a time for affirmative action. 
  • Randomized evaluation of efficacy and safety of ferric carboxymaltose in patients with iron deficiency anaemia and impaired renal function (REPAIR-IDA): rationale and study design. 
  • Recognition and management of masked hypertension: a review and novel approach. 
  • Recommendations for a clinical decision support for the management of individuals with chronic kidney disease. 
  • Reenvisioning the Adult Nephrology Workforce: The Future of Kidney Care in the United States. 
  • Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. 
  • Relationship between stage of kidney disease and incident heart failure in older adults. 
  • Renal Amyloidosis in Deficiency of Adenosine Deaminase 2: Successful Experience With Canakinumab. 
  • Renal Dysfunction Is Associated With Poststroke Discharge Disposition and In-Hospital Mortality: Findings From Get With The Guidelines-Stroke. 
  • Renal Dysfunction and Arrhythmia Association in Patients Receiving Milrinone After Cardiac Surgery. 
  • Renal Dysfunction and In-Hospital Outcomes in Patients With Acute Ischemic Stroke After Intravenous Thrombolytic Therapy. 
  • Renal Dysfunction in Heart Failure With Preserved Ejection Fraction: Insights From the RELAX Trial. 
  • Renal Dysfunction: The Wake-Up Alarm for Chronic Vascular Disease. 
  • Renal Interstitial Fibrosis: An Imperfect Predictor of Kidney Disease Progression in Some Patient Cohorts. 
  • Renal Pre-Competitive Consortium (RPC2): discovering therapeutic targets together. 
  • Renal TGF-beta in HIV-associated kidney diseases. 
  • Renal biopsy and pregnancy. 
  • Renal biopsy in patients with systemic lupus erythematosus: Not just lupus glomerulonephritis! 
  • Renal candidiasis in neonates with candiduria. 
  • Renal colic. Utility of the plain abdominal roentgenogram. 
  • Renal disease in type 1 glycogen storage disease. 
  • Renal disease in type I glycogen storage disease. 
  • Renal dysfunction and cognitive function after coronary artery bypass graft surgery. 
  • Renal function and risk stratification of diabetic and nondiabetic patients undergoing evaluation for coronary artery disease. 
  • Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. 
  • Renal involvement in type I glycogen storage disease. 
  • Renal medullary hypoxia during experimental cardiopulmonary bypass: a pilot study. 
  • Renal scarring and urinary tract infection after successful endoscopic correction of vesicoureteral reflux. 
  • Renal surgery in the new millennium. 
  • Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy. 
  • Reply: Diuretic Strategies and Renal Dysfunction in Heart Failure With Preserved Ejection Fraction. 
  • Reporting of estimated GFR in the primary care clinic. 
  • Reproducibility of the NEPTUNE descriptor-based scoring system on whole-slide images and histologic and ultrastructural digital images. 
  • Retinal arteriolar caliber and urine albumin excretion: the Multi-Ethnic Study of Atherosclerosis. 
  • Retinal microvascular caliber and chronic kidney disease in an Asian population. 
  • Retinal microvasculature as a model to study the manifestations of hypertension. 
  • Retinal vascular geometry predicts incident renal dysfunction in young people with type 1 diabetes. 
  • Reversibility of Glomerular Renal Function Decline in HIV-Uninfected Men and Women Discontinuing Emtricitabine-Tenofovir Disoproxil Fumarate Pre-Exposure Prophylaxis. 
  • Reye's syndrome treated by peritoneal dialysis. 
  • Reye's syndrome. Possible causes and pathogenetic pathways. 
  • Risk factors for cardiovascular disease across the spectrum of older age: the Cardiovascular Health Study. 
  • Risk factors for mortality in patients admitted to intensive care units with pneumonia. 
  • Risk factors for severe clinical events in male and female patients with Fabry disease treated with agalsidase beta enzyme replacement therapy: Data from the Fabry Registry. 
  • Risk of febrile neutropenia among patients with intermediate-grade non-Hodgkin's lymphoma receiving CHOP chemotherapy. 
  • Role of NAD+ and mitochondrial sirtuins in cardiac and renal diseases. 
  • Role of T-cell activation in salt-sensitive hypertension. 
  • Role of cytochrome P4503A in cysteine S-conjugates sulfoxidation and the nephrotoxicity of the sevoflurane degradation product fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether (compound A) in rats. 
  • Role of the angiotensin type 2 receptor gene in congenital anomalies of the kidney and urinary tract, CAKUT, of mice and men. 
  • Role of ubiquitin-like protein FAT10 in epithelial apoptosis in renal disease. 
  • Safety of low-dose radiocontrast for interventional AV fistula salvage in stage 4 chronic kidney disease patients. 
  • Second chances in mineral metabolism. 
  • Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes. 
  • Selenium-binding protein-1 in smooth muscle cells is downregulated in a rhesus monkey model of chronic allograft nephropathy. 
  • Senior-Loken syndrome (familial renal-retinal dystrophy) and Coats' disease. 
  • Sequential changes in bulk renal protein and polyribosomes in the acutely obstructed mouse kidney. 
  • Serum creatinine as marker of kidney function in South Asians: a study of reduced GFR in adults in Pakistan. 
  • Serum creatinine patterns in coronary bypass surgery patients with and without postoperative cognitive dysfunction. 
  • Sex differences in major bleeding with glycoprotein IIb/IIIa inhibitors: results from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) initiative. 
  • Sex differences in progression of kidney disease in sickle cell disease. 
  • Shared features in the pathobiology of babesiosis and malaria. 
  • Significant variation in P2Y12 inhibitor use after peripheral vascular intervention in Medicare beneficiaries. 
  • Small renal mass biopsy--how, what and when: report from an international consensus panel. 
  • Sociodemographic and Kidney Disease Correlates of Nutrient Intakes Among Urban African Americans With Uncontrolled Hypertension. 
  • Solid organ transplantation in primary mitochondrial disease: Proceed with caution. 
  • Special deLIVERy: podocyte injury promotes renal angiotensin II generation from liver-derived angiotensinogen. 
  • Spontaneous perinephric hemorrhage associated with urolithiasis in pregnancy. 
  • Staphylococcus aureus sepsis induces early renal mitochondrial DNA repair and mitochondrial biogenesis in mice. 
  • Statin safety: an assessment using an administrative claims database. 
  • Steady-state serum levels of quinidine and active metabolites in cardiac patients with varying degrees of renal function. 
  • Stimulating Type 1 Angiotensin Receptors on T Lymphocytes Attenuates Renal Fibrosis. 
  • Stimulation of lymphocyte responses by angiotensin II promotes kidney injury in hypertension. 
  • Structural changes in the retinal microvasculature and renal function. 
  • Study of renal safety in amphotericin B lipid complex-treated patients. 
  • Successful management of lower-pole moiety ureteropelvic junction obstruction in a partially duplicated collecting system using minimally invasive retrograde endoscopic techniques. 
  • Surgical transplant physical examination: correlation of renal resistance index and biopsy-proven chronic allograft nephropathy. 
  • Systemic doxorubicin and intraarterial cisplatin preoperative chemotherapy plus postoperative adjuvant chemotherapy in patients with osteosarcoma. 
  • Systemic hypertension and nondiabetic chronic kidney disease: the best evidence-based therapeutic approach today. 
  • TRPC Channels in Proteinuric Kidney Diseases. 
  • Targeting Glomerular Hemodynamics for Kidney Protection. 
  • Temporal trends and predictors in the use of aldosterone antagonists post-acute myocardial infarction. 
  • Temporal trends in U. S. multiple cause of death mortality data: 1968 to 1977. 
  • Temporal trends in maternal medical conditions and stillbirth. 
  • Tetany in a child with AIDS receiving intravenous tobramycin. 
  • The CKD-EPI equation and MDRD study equation find similar prevalence of chronic kidney disease in Asian populations. 
  • The Chronic Kidney Disease Epidemiology Collaboration (CKDEPI) equation best characterizes kidney function in patients being considered for lung transplantation. 
  • The Nephrology Clinician Educator: Pathway and Future. 
  • The Seen and the Unseen: Race and Social Inequities Affecting Kidney Care. 
  • The association between depression and chronic kidney disease and mortality among patients hospitalized with congestive heart failure. 
  • The association of health and income in the elderly: experience from a southern state of Brazil. 
  • The association of lowest hematocrit during cardiopulmonary bypass with acute renal injury after coronary artery bypass surgery. 
  • The association of renal dysfunction and the use of aprotinin in patients undergoing congenital cardiac surgery requiring cardiopulmonary bypass. 
  • The beehive and the merry-go-round in mineral metabolism. 
  • The biomarker niche for fibroblast growth factor 23 testing in CKD. 
  • The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part II: Clinical trial evidence (acute coronary syndromes through renal disease) and future directions. 
  • The continued vital role of electron microscopy in the diagnosis of renal disease/dysfunction. 
  • The effect of aprotinin on outcome after coronary-artery bypass grafting. 
  • The effect of renal dysfunction on short-term outcomes after lumbar fusion. 
  • The effects of dietary patterns on urinary albumin excretion: results of the Dietary Approaches to Stop Hypertension (DASH) Trial. 
  • The excess risk of treated end-stage renal disease in blacks in the United States. 
  • The genetic determinants of renal impairment following cardiac surgery. 
  • The impact of renal function on outcomes of bariatric surgery. 
  • The inducible deletion of Drosha and microRNAs in mature podocytes results in a collapsing glomerulopathy. 
  • The kd/kd mouse is a model of collapsing glomerulopathy. 
  • The kidney research national dialogue: gearing up to move forward. 
  • The landscape of clinical trials in nephrology: a systematic review of Clinicaltrials.gov. 
  • The microvasculature in chronic kidney disease. 
  • The nephritogenic immune response. 
  • The new approach to assignment of ASFA categories--introduction to the fourth special issue: clinical applications of therapeutic apheresis. 
  • The quality of cardiovascular disease care for adolescents with kidney disease: a Midwest Pediatric Nephrology Consortium study. 
  • The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data. 
  • The renal manifestations and outcome of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in adults. 
  • The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up. 
  • The role of complement dysregulation in AMD mouse models. 
  • The role of systemic hypertension in the progression of nondiabetic renal disease. 
  • The role of type 1 angiotensin receptors on T lymphocytes in cardiovascular and renal diseases. 
  • The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 years. 
  • The spectrum of kidney disease in patients with AIDS in the era of antiretroviral therapy. 
  • The state of the blog: the first year of eAJKD. 
  • The value of urodynamic studies in infants less than 1 year old with congenital spinal dysraphism. 
  • The varying roles of macrophages in kidney injury and repair. 
  • Therapeutic apheresis before and after kidney transplantation. 
  • Tobacco exposure in adults and children with proteinuric glomerulopathies: a NEPTUNE cohort study. 
  • Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: results from the ATLAS trial. The Assessment of Treatment with Lisinopril and Survival. 
  • Traditional and novel cardiovascular risk factors for retinal vein occlusion: the multiethnic study of atherosclerosis. 
  • Trajectories of Changes in Renal Function in Patients with Acute Heart Failure. 
  • Transduction of renal cells in vitro and in vivo by adeno-associated virus gene therapy vectors. 
  • Treatment considerations for patients with neuropathic pain and other medical comorbidities. 
  • Treatment of acute graft-versus-host disease after allogeneic marrow transplantation. Randomized study comparing corticosteroids and cyclosporine. 
  • Tweeting the meeting: an in-depth analysis of Twitter activity at Kidney Week 2011. 
  • Twist1 in Infiltrating Macrophages Attenuates Kidney Fibrosis via Matrix Metallopeptidase 13-Mediated Matrix Degradation. 
  • Twist1 in T Lymphocytes Augments Kidney Fibrosis after Ureteral Obstruction. 
  • Type 1 angiotensin receptors on macrophages ameliorate IL-1 receptor-mediated kidney fibrosis. 
  • Type 2 angiotensin II receptor expression in human renal allografts: an association with chronic allograft nephropathy. 
  • Type I glycogen storage disease: kidney involvement, pathogenesis and its treatment. 
  • Ultrafiltration in Acute Heart Failure: Implications of Ejection Fraction and Early Response to Treatment From CARRESS-HF. 
  • Understanding kidney care needs and implementation strategies in low- and middle-income countries: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference. 
  • Unintended Consequences of COVID-19 Social Distancing Among Older Adults With Kidney Disease. 
  • Update in podocyte biology: putting one's best foot forward. 
  • Updated guidelines for the diagnosis and management of high blood pressure: implications for clinical practice in nephrology. 
  • Ureteroscopic laser papillotomy to treat papillary calcifications associated with chronic flank pain. 
  • Urinary Angiotensinogen Could Be a Prognostic Marker of Renoprotective Effects of Alogliptin in Patients with Type 2 Diabetes. 
  • Urinary Single-Cell Profiling Captures the Cellular Diversity of the Kidney. 
  • Urine NGAL as a biomarker of kidney damage after on- and off-pump coronary artery bypass graft surgery: a prospective pilot study. 
  • Urologic complications in renal transplantation. 
  • Urologic surgery. 
  • Use of Race in Kidney Research and Medicine: Concepts, Principles, and Practice. 
  • Use of aspirin associates with longer primary patency of hemodialysis grafts. 
  • Use of polyethylene glycol-modified uricase (PEG-uricase) to treat hyperuricemia in a patient with non-Hodgkin lymphoma. 
  • Use of remifentanil in infants. 
  • Variations in levels of blood pressure: of prognostic value or not? 
  • Vascular obstruction of the superior renal infundibulum in children. 
  • Viral associations with kidney disease diagnosis and altered kidney metatranscriptome by kidney function. 
  • Virtual reality surgical simulation in endoscopic urologic surgery. 
  • Vitamin D in patients with kidney disease: cautiously optimistic. 
  • Weekend admission and treatment of patients with renal colic: a case of avoidable variation? 
  • Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. 
  • Workshop on late renal allograft dysfunction. 
  • Xanthogranulomatous pyelonephritis with a nephrocutaneous fistula. 
  • [Most recommended timing to start medication for hypertensive patients]. 
  • [Renal erythropoietin-producing cells and kidney disease]. 
  • [Renal fibrosis and anemia]. 
  • alpha 2u-Globulin nephropathy, renal cell proliferation, and dosimetry of inhaled tert-butyl alcohol in male and female F-344 rats. 
• 

  Keywords of People

  • Alexander, John Hunter Peel, Professor of Medicine, Medicine, Cardiology
  • Berchuck, Andrew, James M. Ingram Distinguished Professor of Gynecologic Oncology, Obstetrics and Gynecology, Gynecologic Oncology
  • Boulware, L. Ebony, Adjunct Professor in the Department of Medicine, Duke Science & Society
  • Bradford, William Dalton, Professor of Pathology, Pathology
  • Buckley, Anne Frances, Assistant Professor of Pathology, Pathology
  • Davenport, Tina, Biostatistician, Senior, Biostatistics & Bioinformatics
  • Granger, Christopher Bull, Professor of Medicine, School of Nursing
  • Green, Jennifer Brigitte, Professor of Medicine, Medicine, Endocrinology, Metabolism, and Nutrition
  • Johnson, G. Allan, Charles E. Putman University Distinguished Professor of Radiology, Biomedical Engineering
  • Mentz, Robert John, Associate Professor of Medicine, Medicine, Cardiology
  • Middleton, John Paul, Professor of Medicine, Medicine, Nephrology
  • Mohottige, Dinushika, Adjunct Assistant Professor in the Department of Medicine, Medicine, Nephrology
  • Musah, Samira, Assistant Professor in the Department of Biomedical Engineering, Biomedical Engineering
  • O'Connor, Christopher Michael, Adjunct Professor in the Department of Medicine, Medicine, Clinical Pharmacology
  • Patel, Uptal Dinesh, Adjunct Professor in the Department of Medicine, Medicine, Nephrology
  • Preminger, Glenn Michael, James F. Glenn, M.D. Distinguished Professor of Urology, Surgery, Urology
  • Routh, Jonathan Charles, Paul H. Sherman, M.D. Distinguished Associate Professor of Surgery, Pediatrics
  • Sparks, Matthew A., Associate Professor of Medicine, Medicine, Nephrology
  • Sullivan, Daniel Carl, Professor Emeritus of Radiology, Radiology
  • Svetkey, Laura Pat, Professor of Medicine, Medicine
  • Swaminathan, Madhav, Professor of Anesthesiology, Anesthesiology, Cardiothoracic